Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,048
Award facts
- Contract value 100% obligated
- $27,047.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,047.91 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 16, 2026, with an ultimate completion date of January 27, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The underlying IDC, designated as contract SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V program authorizes firm fixed-price delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FEMRB?
SPE2DU26FEMRB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DU26FEMRB worth?
The government has obligated $27,048 on SPE2DU26FEMRB.
Is contract SPE2DU26FEMRB an order under another contract?
Yes. SPE2DU26FEMRB is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRB competed?
The extent of competition for SPE2DU26FEMRB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award